Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study

Background: Heart failure (HF) is a multifactorial syndrome with pathophysiological complexities still not fully understood. Higher mean platelet volume (MPV), a potential marker of platelet activation, and high concentrations of parathyroid hormone (PTH) have been implicated in the pathogenesis of...

Full description

Bibliographic Details
Main Authors: Bianca Dahlen, Felix Müller, Sven-Oliver Tröbs, Marc William Heidorn, Andreas Schulz, Natalie Arnold, M. Iris Hermanns, Sören Schwuchow-Thonke, Jürgen H. Prochaska, Tommaso Gori, Hugo ten Cate, Karl J. Lackner, Thomas Münzel, Philipp S. Wild, Marina Panova-Noeva
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
MPV
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.682521/full
id doaj-67a7eef88b4a441081f76eaad8041719
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Bianca Dahlen
Felix Müller
Felix Müller
Sven-Oliver Tröbs
Sven-Oliver Tröbs
Sven-Oliver Tröbs
Marc William Heidorn
Marc William Heidorn
Andreas Schulz
Natalie Arnold
Natalie Arnold
M. Iris Hermanns
Sören Schwuchow-Thonke
Jürgen H. Prochaska
Jürgen H. Prochaska
Jürgen H. Prochaska
Tommaso Gori
Tommaso Gori
Hugo ten Cate
Karl J. Lackner
Karl J. Lackner
Thomas Münzel
Thomas Münzel
Philipp S. Wild
Philipp S. Wild
Philipp S. Wild
Marina Panova-Noeva
Marina Panova-Noeva
spellingShingle Bianca Dahlen
Felix Müller
Felix Müller
Sven-Oliver Tröbs
Sven-Oliver Tröbs
Sven-Oliver Tröbs
Marc William Heidorn
Marc William Heidorn
Andreas Schulz
Natalie Arnold
Natalie Arnold
M. Iris Hermanns
Sören Schwuchow-Thonke
Jürgen H. Prochaska
Jürgen H. Prochaska
Jürgen H. Prochaska
Tommaso Gori
Tommaso Gori
Hugo ten Cate
Karl J. Lackner
Karl J. Lackner
Thomas Münzel
Thomas Münzel
Philipp S. Wild
Philipp S. Wild
Philipp S. Wild
Marina Panova-Noeva
Marina Panova-Noeva
Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study
Frontiers in Cardiovascular Medicine
heart failure
MPV
platelet count
parathyroid hormone
heart failure with preserved ejection fraction
heart failure with reduced ejection fraction
author_facet Bianca Dahlen
Felix Müller
Felix Müller
Sven-Oliver Tröbs
Sven-Oliver Tröbs
Sven-Oliver Tröbs
Marc William Heidorn
Marc William Heidorn
Andreas Schulz
Natalie Arnold
Natalie Arnold
M. Iris Hermanns
Sören Schwuchow-Thonke
Jürgen H. Prochaska
Jürgen H. Prochaska
Jürgen H. Prochaska
Tommaso Gori
Tommaso Gori
Hugo ten Cate
Karl J. Lackner
Karl J. Lackner
Thomas Münzel
Thomas Münzel
Philipp S. Wild
Philipp S. Wild
Philipp S. Wild
Marina Panova-Noeva
Marina Panova-Noeva
author_sort Bianca Dahlen
title Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study
title_short Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study
title_full Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study
title_fullStr Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study
title_full_unstemmed Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study
title_sort sex-specific relationship between parathyroid hormone and platelet indices in phenotypes of heart failure—results from the myovasc study
publisher Frontiers Media S.A.
series Frontiers in Cardiovascular Medicine
issn 2297-055X
publishDate 2021-06-01
description Background: Heart failure (HF) is a multifactorial syndrome with pathophysiological complexities still not fully understood. Higher mean platelet volume (MPV), a potential marker of platelet activation, and high concentrations of parathyroid hormone (PTH) have been implicated in the pathogenesis of HF.Aim: This study aims to investigate sex-specifically the association between PTH concentrations and platelet indices in phenotypes of HF.Methods and Results: PTH and platelet indices (MPV and platelet count) were available in 1,896 participants from the MyoVasc study in Mainz, Germany. Multivariable linear regression models, adjusted for age, sex, season, vitamin D status, cardiovascular risk factors, comorbidities, estimated glomerular filtration rate, and medication, were used to assess the associations between platelet indices and PTH. The results showed distinct sex-specific associations between PTH and platelet indices. A positive association between PTH and MPV was found in females with symptomatic HF with reduced ejection fraction (HFrEF) only [β = 0.60 (0.19; 1.00)]. Platelet count was inversely associated with PTH in male HFrEF individuals [β = −7.6 (−15; −0.30)] and in both males and females with HF with preserved ejection fraction (HFpEF).Conclusion: This study reports differential, sex-specific relationships between PTH and platelet indices in HF individuals independent of vitamin D status and clinical profile. Particularly in phenotypes of symptomatic HF, distinct associations were observed, suggesting a sex-specific mechanism involved in the interaction between PTH and platelets.
topic heart failure
MPV
platelet count
parathyroid hormone
heart failure with preserved ejection fraction
heart failure with reduced ejection fraction
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.682521/full
work_keys_str_mv AT biancadahlen sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT felixmuller sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT felixmuller sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT svenolivertrobs sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT svenolivertrobs sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT svenolivertrobs sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT marcwilliamheidorn sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT marcwilliamheidorn sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT andreasschulz sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT nataliearnold sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT nataliearnold sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT mirishermanns sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT sorenschwuchowthonke sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT jurgenhprochaska sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT jurgenhprochaska sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT jurgenhprochaska sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT tommasogori sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT tommasogori sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT hugotencate sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT karljlackner sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT karljlackner sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT thomasmunzel sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT thomasmunzel sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT philippswild sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT philippswild sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT philippswild sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT marinapanovanoeva sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
AT marinapanovanoeva sexspecificrelationshipbetweenparathyroidhormoneandplateletindicesinphenotypesofheartfailureresultsfromthemyovascstudy
_version_ 1721375168358514688
spelling doaj-67a7eef88b4a441081f76eaad80417192021-06-16T09:44:21ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-06-01810.3389/fcvm.2021.682521682521Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc StudyBianca Dahlen0Felix Müller1Felix Müller2Sven-Oliver Tröbs3Sven-Oliver Tröbs4Sven-Oliver Tröbs5Marc William Heidorn6Marc William Heidorn7Andreas Schulz8Natalie Arnold9Natalie Arnold10M. Iris Hermanns11Sören Schwuchow-Thonke12Jürgen H. Prochaska13Jürgen H. Prochaska14Jürgen H. Prochaska15Tommaso Gori16Tommaso Gori17Hugo ten Cate18Karl J. Lackner19Karl J. Lackner20Thomas Münzel21Thomas Münzel22Philipp S. Wild23Philipp S. Wild24Philipp S. Wild25Marina Panova-Noeva26Marina Panova-Noeva27Preventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyDZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, Mainz, GermanyClinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyPreventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyDZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, Mainz, GermanyClinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyDZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, Mainz, GermanyClinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyPreventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyPreventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyDZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, Mainz, GermanyPreventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyCardiology I, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyPreventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyDZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, Mainz, GermanyClinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyDZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, Mainz, GermanyCardiology I, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyLaboratory for Clinical Thrombosis and Hemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, NetherlandsDZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, Mainz, GermanyInstitute for Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyDZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, Mainz, GermanyCardiology I, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyPreventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyDZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, Mainz, GermanyClinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyDZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, Mainz, GermanyClinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanyBackground: Heart failure (HF) is a multifactorial syndrome with pathophysiological complexities still not fully understood. Higher mean platelet volume (MPV), a potential marker of platelet activation, and high concentrations of parathyroid hormone (PTH) have been implicated in the pathogenesis of HF.Aim: This study aims to investigate sex-specifically the association between PTH concentrations and platelet indices in phenotypes of HF.Methods and Results: PTH and platelet indices (MPV and platelet count) were available in 1,896 participants from the MyoVasc study in Mainz, Germany. Multivariable linear regression models, adjusted for age, sex, season, vitamin D status, cardiovascular risk factors, comorbidities, estimated glomerular filtration rate, and medication, were used to assess the associations between platelet indices and PTH. The results showed distinct sex-specific associations between PTH and platelet indices. A positive association between PTH and MPV was found in females with symptomatic HF with reduced ejection fraction (HFrEF) only [β = 0.60 (0.19; 1.00)]. Platelet count was inversely associated with PTH in male HFrEF individuals [β = −7.6 (−15; −0.30)] and in both males and females with HF with preserved ejection fraction (HFpEF).Conclusion: This study reports differential, sex-specific relationships between PTH and platelet indices in HF individuals independent of vitamin D status and clinical profile. Particularly in phenotypes of symptomatic HF, distinct associations were observed, suggesting a sex-specific mechanism involved in the interaction between PTH and platelets.https://www.frontiersin.org/articles/10.3389/fcvm.2021.682521/fullheart failureMPVplatelet countparathyroid hormoneheart failure with preserved ejection fractionheart failure with reduced ejection fraction